首页> 外文期刊>Drug delivery. >Enantioselective release of controlled delivery granules based on molecularly imprinted polymers.
【24h】

Enantioselective release of controlled delivery granules based on molecularly imprinted polymers.

机译:基于分子印迹聚合物的对映控制颗粒的对映选择性释放。

获取原文
获取原文并翻译 | 示例
           

摘要

The objectives of our study were two fold: to examine enantioselective release of controlled delivery granules based on molecularly imprinted polymers (MIPs) for various racemic drugs, including ibuprofen and ketoprofen (NSAIDs) and propranolol (beta-blockers); to evaluate the use of controlled delivery granules containing a combination of different MIPs for the multiple simultaneous enantioselective-controlled delivery of mixed racemic drugs. In this work, the MIP beads selective to S-Ibuprofen, S-ketoprofen, and R-propranolol were prepared using multistep swelling and thermal polymerization method. Afterward, the MIP beads were formulated with racemate of the chiral drugs and a binder and followed by granulation. Then, the enantioselective release of racemic drugs from the prepared MIP granules was investigated by an in vitro dissolution test using a chiral HPLC for assays of enantiomers. The influence of drug/polymer ratio and medium pH on the selective enantiomeric release of MIP granules was explored. Further, the release of the enantiomers of racemic ibuprofen and racemic ketoprofen from the granule containing two MIPs - S-ibuprofen MIP and S-ketoprofen MIP - was examined. The release profiles of both S-ibuprofen MIP granule and R-propranolol MIP granule exhibited differential release of enantiomers. Also, the findings indicated the stereoselective retardation of those controlled delivery granules as well as the influence of MIP formulation on enantioselective release mechanism. The enantioselective release of S-ibuprofen MIP granule and R-propranolol MIP granule appeared to depend on polymer loading and medium pH. In this case, the drug/polymer ratio of 1:25 showed the best enantioselective release with initial enantiomeric excess of 100%. On the other hand, the enantioselectivity of both granules was the greatest in buffer pH 7.4. Furthermore, the efficiency in enantioselective release of the combined MIP granule was higher than its relative single MIP granules, as a result of the cross-reactivities of the MIPs. In our study, controlled delivery granules based on MIPs demonstrated significant enantioselective release for several chiral drugs, and thus it may be developed as a tool to administer chiral pharmaceutical as a single enantiomer.
机译:我们的研究目标有两个方面:检查基于分子印迹聚合物(MIP)的各种外消旋药物,包括布洛芬和酮洛芬(NSAIDs)和普萘洛尔(β受体阻滞剂)的对映释放对映体。评估含有不同MIP组合的控释颗粒用于混合消旋药物的多种同时对映选择性控释的用途。在这项工作中,使用多步溶胀和热聚合方法制备了对S-布洛芬,S-酮洛芬和R-普萘洛尔具有选择性的MIP珠。之后,将MIP珠与手性药物的外消旋物和粘合剂一起配制,然后制粒。然后,通过使用手性HPLC的体外溶出试验研究外消旋药物从制备的MIP颗粒中的对映选择性释放,以测定对映异构体。探索了药物/聚合物比和中等pH对MIP颗粒选择性对映体释放的影响。此外,研究了外消旋布洛芬和外消旋酮洛芬的对映异构体从含有两个MIPs-S-布洛芬MIP和S-酮洛芬MIP的颗粒中的释放。 S-布洛芬MIP颗粒和R-普萘洛尔MIP颗粒的释放曲线均显示对映异构体的差异释放。同样,这些发现表明那些受控递送颗粒的立体选择性延迟以及MIP制剂对对映选择性释放机理的影响。 S-布洛芬MIP颗粒和R-普萘洛尔MIP颗粒的对映选择性释放似乎取决于聚合物的负载量和中等pH。在这种情况下,药物/聚合物的比例为1:25表现出最佳的对映选择性释放,初始对映体过量为100%。另一方面,两种颗粒的对映选择性在pH 7.4的缓冲液中最大。此外,由于MIP的交叉反应性,组合的MIP颗粒的对映选择性释放的效率高于其相对的单个MIP颗粒。在我们的研究中,基于MIP的控释颗粒对几种手性药物表现出显着的对映选择性释放,因此它可能被开发为一种将手性药物作为单一对映体给药的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号